SpeeDx and SynGenis Partner for Custom Oligonucleotide Synthesis
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"We have invested considerable resources into our production scale-up processes to support the increase in testing seen as a result of the global pandemic," said Tom Lin, SpeeDx Director of Global Operations. "Enhancing our access to quality raw materials ensures we remain committed to maintaining supply chain security for our customers worldwide."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
SYDNEY & BENTLEY, Australia -- Businesswire -- SpeeDx Pty, Ltd. a developer of innovative molecular diagnostic solutions announced investment in SynGenis Pty Ltd., an experienced oligonucleotide manufacturer based in Western Australia. The partnership will bolster internal capacity of SpeeDx to support large-scale increases in manufacturing while developing and expanding sovereign capacity of important raw materials used in molecular diagnostics.
“We have invested considerable resources into our production scale-up processes to support the increase in testing seen as a result of the global pandemic,” said Tom Lin, SpeeDx Director of Global Operations. “Enhancing our access to quality raw materials ensures we remain committed to maintaining supply chain security for our customers worldwide.”
The increased demand for COVID-19 diagnostics has in turn increased global demand for the oligonucleotide raw materials that form the basis of molecular diagnostic products. In addition to this supply chain burden, reduced flights and increased customs challenges entering Australia has complicated freight and delivery times from overseas suppliers. SpeeDx investment in local oligonucleotide manufacturing reduces supply chain risk and develops stronger sovereign capacity for critical diagnostics for a more robust national health infrastructure.
“As Australia’s experienced commercial oligonucleotide manufacturer with significant expertise, we are delighted to have this strategic partnership to supply custom oligonucleotides with highest quality and fast turnaround time,” said Rakesh Veedu, SynGenis Founder and Managing Director. SynGenis Chairman Steve Arnott said “The partnership with SpeeDx is a strong vote of confidence in the capability and capacity of Syngenis staff and operations and provides a significant platform for our future development.
In addition to securing local supply chain, SpeeDx investment in local industry serves to fast track the growth and expand the reach of SynGenis in the global diagnostic market.
About SpeeDx
Founded in 2009, SpeeDx is an Australian-based private company with subsidiary offices in Austin, Texas and London, UK, with distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information on SpeeDx please see: https://plexpcr.com
About SynGenis
Founded in 2020, SynGenis is an Australian oligonucleotide manufacturing company with excellent facilities based in Bentley Technology Park. SynGenis specializes in the production and supply of high-quality oligonucleotides including DNA, RNA and modified oligonucleotides for use in RNA therapeutics, diagnostics and drug delivery applications. With our expertise in oligonucleotide synthesis chemistry and state-of-the-art equipments, we support our customers from the R&D phase right through to commercial production. For more information on SynGenis please see: https://www.syngenis.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210927005329/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:SpeeDx Pty. Ltd.
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- ‘난타’의 송승환 감독, 한국형 에든버러 축제 만든다 - 뉴스와이어
- 기아, 더 뉴 EV6 티저 이미지 공개 - 뉴스와이어
- 이니스프리, 최대 70% 할인 ‘5월 슈퍼 빅세일’ 시작 - 뉴스와이어
- LS일렉트릭, 미래 주도할 친환경 스마트 전력 솔루션 총출동 - 뉴스와이어
- 마이원픽, K-POP SEOUL과 업무 협약 체결… 서울가요대상 월간투표 공동 진행 - 뉴스와이어
- 삼성전자, 인천공항에서 ‘갤럭시 S24 시리즈’ 무료 대여 서비스 실시 - 뉴스와이어
- 서울대 공대 남기태 교수-김영민 교수 공동 연구팀, 나노입자 입체구조 예측 위한 AI 알고리즘 개
- 김규리 작가 7번째 전시회 ‘Lost Fangs’ 개최 - 뉴스와이어
- 무지방·고단백 설계, 매일유업 ‘매일 바이오 프로틴 요거트’ 출시 - 뉴스와이어
- 삼성SDS, 생성형 AI 서비스 ‘FabriX 및 Brity Copilot’ 출시 - 뉴스와이어